Support First Things by turning your adblocker off or by making a  donation. Thanks!

New Down Syndrome detection procedures will soon be introduced to the market, using only a sample of the mother’s blood, hopefully reducing the need for more dangerous, invasive tests. Researchers say that the new procedure is not reliable enough to replace the two more dangerous techniques already used, amniocentesis and chorionic villus sampling, but “with development,” says Dr. Stephen A. Brown, associate professor of obstetrics and gynecology at the University of Vermont, “you will have dramatically fewer procedures.”

A new method that circumvents the sometimes problematic tests used for detecting Down Syndrome in pre-natal children is certainly welcome, but it nonetheless brings to mind the staggering rate of aborted Down Syndrome children, a steady  92%. Hopefully this new test will simply help mothers avoid the dangers involved in detecting Down Syndrome in their pre-natal children and prepare them to welcome a new life into the world, no matter what the results.

 

Dear Reader,

While I have you, can I ask you something? I’ll be quick.

Twenty-five thousand people subscribe to First Things. Why can’t that be fifty thousand? Three million people read First Things online like you are right now. Why can’t that be four million?

Let’s stop saying “can’t.” Because it can. And your year-end gift of just $50, $100, or even $250 or more will make it possible.

How much would you give to introduce just one new person to First Things? What about ten people, or even a hundred? That’s the power of your charitable support.

Make your year-end gift now using this secure link or the button below.
GIVE NOW

Comments are visible to subscribers only. Log in or subscribe to join the conversation.

Tags

Loading...

Filter First Thoughts Posts

Related Articles